Treatment of Secondary Hemophagocytic Lymphohistiocytosis Associated With Diffuse Large B-cell Lymphoma Using Loncastuximab Tesirine As Lymphoma-Directed Therapy.

Saved in:
Bibliographic Details
Title: Treatment of Secondary Hemophagocytic Lymphohistiocytosis Associated With Diffuse Large B-cell Lymphoma Using Loncastuximab Tesirine As Lymphoma-Directed Therapy.
Authors: Schieber T; Hematology/Oncology, The University of Kansas Cancer Center, Kansas City, USA., Snyder J; Hematology, The University of Kansas Cancer Center, Kansas City, USA., Lutfi F; Hematology, The University of Kansas Cancer Center, Kansas City, USA.
Source: Cureus [Cureus] 2024 Sep 29; Vol. 16 (9), pp. e70450. Date of Electronic Publication: 2024 Sep 29 (Print Publication: 2024).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2168-8184
DOI:10.7759/cureus.70450